96 related articles for article (PubMed ID: 35169126)
1. Protein C receptor maintains cancer stem cell properties via activating lipid synthesis in nasopharyngeal carcinoma.
Zhang P; He Q; Wang Y; Zhou G; Chen Y; Tang L; Zhang Y; Hong X; Mao Y; He Q; Yang X; Liu N; Ma J
Signal Transduct Target Ther; 2022 Feb; 7(1):46. PubMed ID: 35169126
[TBL] [Abstract][Full Text] [Related]
2. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models.
Li JY; Zhao Y; Gong S; Wang MM; Liu X; He QM; Li YQ; Huang SY; Qiao H; Tan XR; Ye ML; Zhu XH; He SW; Li Q; Liang YL; Chen KL; Huang SW; Li QJ; Ma J; Liu N
Nat Commun; 2023 Feb; 14(1):865. PubMed ID: 36797289
[TBL] [Abstract][Full Text] [Related]
3. Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
Tang LL; Guo R; Zhang N; Deng B; Chen L; Cheng ZB; Huang J; Hu WH; Huang SH; Luo WJ; Liang JH; Zheng YM; Zhang F; Mao YP; Li WF; Zhou GQ; Liu X; Chen YP; Xu C; Lin L; Liu Q; Du XJ; Zhang Y; Sun Y; Ma J
JAMA; 2022 Aug; 328(8):728-736. PubMed ID: 35997729
[TBL] [Abstract][Full Text] [Related]
4. A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinoma.
Liang YL; Zhang Y; Tan XR; Qiao H; Liu SR; Tang LL; Mao YP; Chen L; Li WF; Zhou GQ; Zhao Y; Li JY; Li Q; Huang SY; Gong S; Zheng ZQ; Li ZX; Sun Y; Jiang W; Ma J; Li YQ; Liu N
Nat Commun; 2022 May; 13(1):2996. PubMed ID: 35637194
[TBL] [Abstract][Full Text] [Related]
5. Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity.
Gao Y; Zheng X; Chang B; Lin Y; Huang X; Wang W; Ding S; Zhan W; Wang S; Xiao B; Huo L; Yu Y; Chen Y; Gong R; Wu Y; Zhang R; Zhong L; Wang X; Chen Q; Gao S; Jiang Z; Wei D; Kang T
Cell Res; 2022 Dec; 32(12):1086-1104. PubMed ID: 36280710
[TBL] [Abstract][Full Text] [Related]
6. CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization.
Hong X; Li Q; Li J; Chen K; He Q; Zhao Y; Liang Y; Zhao Y; Qiao H; Liu N; Ma J; Li Y
Clin Cancer Res; 2022 Oct; 28(20):4521-4535. PubMed ID: 35917517
[TBL] [Abstract][Full Text] [Related]
7. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.
Qiao H; Tan XR; Li H; Li JY; Chen XZ; Li YQ; Li WF; Tang LL; Zhou GQ; Zhang Y; Liang YL; He QM; Zhao Y; Huang SY; Gong S; Li Q; Ye ML; Chen KL; Sun Y; Ma J; Liu N
JAMA Oncol; 2022 Sep; 8(9):1301-1309. PubMed ID: 35834269
[TBL] [Abstract][Full Text] [Related]
8. Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.
Zhang Y; Chen L; Hu GQ; Zhang N; Zhu XD; Yang KY; Jin F; Shi M; Chen YP; Hu WH; Cheng ZB; Wang SY; Tian Y; Wang XC; Sun Y; Li JG; Li WF; Li YH; Mao YP; Zhou GQ; Sun R; Liu X; Guo R; Long GX; Liang SQ; Li L; Huang J; Long JH; Zang J; Liu QD; Zou L; Su QF; Zheng BM; Xiao Y; Guo Y; Han F; Mo HY; Lv JW; Du XJ; Xu C; Liu N; Li YQ; Xie FY; Sun Y; Ma J; Tang LL
J Clin Oncol; 2022 Aug; 40(22):2420-2425. PubMed ID: 35709465
[No Abstract] [Full Text] [Related]
9. Cisplatin in Liver Cancer Therapy.
Hamaya S; Oura K; Morishita A; Masaki T
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446035
[TBL] [Abstract][Full Text] [Related]
10. The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment.
Lv J; Wei Y; Yin JH; Chen YP; Zhou GQ; Wei C; Liang XY; Zhang Y; Zhang CJ; He SW; He QM; Huang ZL; Guan JL; Shen JY; Li XM; Li JY; Li WF; Tang LL; Mao YP; Guo R; Sun R; Zheng YH; Zhou WW; Xiong KX; Wang SQ; Jin X; Liu N; Li GB; Kuang DM; Sun Y; Ma J
Nat Med; 2023 Jun; 29(6):1424-1436. PubMed ID: 37280275
[TBL] [Abstract][Full Text] [Related]
11. Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.
Mao YP; Wang SX; Gao TS; Zhang N; Liang XY; Xie FY; Zhang Y; Zhou GQ; Guo R; Luo WJ; Li YJ; Liang SQ; Lin L; Li WF; Liu X; Xu C; Chen YP; Lv JW; Huang SH; Liu LZ; Li JB; Tang LL; Chen L; Sun Y; Ma J
BMJ; 2023 Feb; 380():e072133. PubMed ID: 36746459
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance.
Lin M; Zhang XL; You R; Liu YP; Cai HM; Liu LZ; Liu XF; Zou X; Xie YL; Zou RH; Zhang YN; Sun R; Feng WY; Wang HY; Tao GH; Li HJ; Huang WJ; Zhang C; Huang PY; Wang J; Zhao Q; Yang Q; Zhang HW; Liu T; Li HF; Jiang XB; Tang J; Gu YK; Yu T; Wang ZQ; Feng L; Kang TB; Zuo ZX; Chen MY
Nat Commun; 2023 Feb; 14(1):610. PubMed ID: 36739462
[TBL] [Abstract][Full Text] [Related]
13. TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma.
Wang YQ; Wu DH; Wei D; Shen JY; Huang ZW; Liang XY; Cho WCS; Ma J; Lv J; Chen YP
Sci Adv; 2023 Jan; 9(1):eadd0960. PubMed ID: 36608137
[TBL] [Abstract][Full Text] [Related]
14. Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma.
Wu L; Wu W; Zhang J; Zhao Z; Li L; Zhu M; Wu M; Wu F; Zhou F; Du Y; Chai RC; Zhang W; Qiu X; Liu Q; Wang Z; Li J; Li K; Chen A; Jiang Y; Xiao X; Zou H; Srivastava R; Zhang T; Cai Y; Liang Y; Huang B; Zhang R; Lin F; Hu L; Wang X; Qian X; Lv S; Hu B; Zheng S; Hu Z; Shen H; You Y; Verhaak RGW; Jiang T; Wang Q
Cancer Discov; 2022 Dec; 12(12):2820-2837. PubMed ID: 36122307
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy in nasopharyngeal carcinoma- A systematic review of phase III clinical trials.
Nazeer F; Poulose JV; Kainickal CT
Cancer Treat Res Commun; 2022; 32():100589. PubMed ID: 35724627
[TBL] [Abstract][Full Text] [Related]
16. DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway.
Ding S; Gao Y; Lv D; Tao Y; Liu S; Chen C; Huang Z; Zheng S; Hu Y; Chow LK; Wei Y; Feng P; Dai W; Wang X; Xia Y
EBioMedicine; 2022 Jul; 81():104100. PubMed ID: 35689852
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 Screens Reveal that Hexokinase 2 Enhances Cancer Stemness and Tumorigenicity by Activating the ACSL4-Fatty Acid β-Oxidation Pathway.
Li H; Song J; He Y; Liu Y; Liu Z; Sun W; Hu W; Lei QY; Hu X; Chen Z; He X
Adv Sci (Weinh); 2022 Jul; 9(21):e2105126. PubMed ID: 35603967
[TBL] [Abstract][Full Text] [Related]
18. Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.
Li WZ; Lv X; Hu D; Lv SH; Liu GY; Liang H; Ye YF; Yang W; Zhang HX; Yuan TZ; Wang DS; Lu N; Ke LR; Tang WB; Tong LH; Chen ZJ; Liu T; Cao KJ; Mo HY; Guo L; Zhao C; Chen MY; Chen QY; Huang PY; Sun R; Qiu F; Luo DH; Wang L; Hua YJ; Tang LQ; Qian CN; Mai HQ; Guo X; Xiang YQ; Xia WX
JAMA Oncol; 2022 May; 8(5):706-714. PubMed ID: 35323856
[TBL] [Abstract][Full Text] [Related]
19. Single-cell profiling of human CD127
He Y; Luo J; Zhang G; Jin Y; Wang N; Lu J; Li C; Guo X; Qin N; Dai J; Chen Y
Hepatology; 2022 Oct; 76(4):1013-1029. PubMed ID: 35243668
[TBL] [Abstract][Full Text] [Related]
20. Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.
Tang LL; Huang CL; Zhang N; Jiang W; Wu YS; Huang SH; Mao YP; Liu Q; Li JB; Liang SQ; Qin GJ; Hu WH; Sun Y; Xie FY; Chen L; Zhou GQ; Ma J
Lancet Oncol; 2022 Apr; 23(4):479-490. PubMed ID: 35240053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
